Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
Date:5/5/2009

, were $59.6 million, compared with $72.8 million at December 31, 2008. Management currently believes the existing cash and investment securities will provide adequate resources to fund the Company's operations into the first quarter of 2010.

Goals and Objectives

During the remainder of 2009 Poniard expects to:

  • Present progression-free survival data and safety data from two ongoing Phase 2 trials of picoplatin as first-line treatment for metastatic colorectal and castration-resistant prostate cancers (CRPC) at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO); the Company plans to hold an investor event featuring oncology experts at ASCO on Sunday, May 31;
  • Report top-line results from the pivotal Phase 3 SPEAR trial in SCLC in the second half 2009; and
  • Initiate submission of a New Drug Application with the U.S. Food and Drug Administration for picoplatin as a second-line treatment for SCLC, targeting approval and commercialization in 2010.

About Small Cell Lung Cancer

SCLC is the most aggressive form of lung cancer and tends to be widespread by the time of diagnosis. According to the American Cancer Society, in the U.S. in 2008 an estimated 32,000 new cases of SCLC were expected to be diagnosed and 52,000 SCLC patients were treated with therapy (American Cancer Society, Cancer Facts and Figures 2009). Patients with SCLC have few treatment options and a poor prognosis. Effective second-line treatment for SCLC is a major unmet medical need.

About Colorectal Cancer

CRC is the third most common cancer in both American men and women, and the third leading cause of cancer death in the U.S. In 2008, an estimated 148,810 new cases of colon and rectal cancer were expected to be diagnosed in the U.S., with an esti
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  Ardelyx, Inc. (NASDAQ: ARDX ), ... metabolic diseases, today announced that the Company will host ... 8:00 a.m.- 1:00 pm EDT in New ... senior management team will present an overview of the ... has completed Phase 2b clinical trials for the treatment ...
(Date:6/30/2015)... MIRAMAR BEACH, Fla. , June 30, 2015  July ... our country,s declaration of independence, and the spirit and people ... For Heroes Foundation has partnered with USA ... cards, to help increase funding for programs that empower independence ... across the country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... 30, 2015  Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and ... results from a Category 3 human abuse ... extended-release, oral oxycodone product candidate in late-stage ... severe enough to require daily, around-the-clock opioid ...
Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Supply Company (LABSCO), the largest privately held supplier of ... office laboratories, reference labs and other non-acute care settings ... leadership team with the new appointment of George Willett ... Willett,s career has included over 17 years serving as ...
... 29, 2011 Faith Community Hospital recently joined the ranks ... meaningful use of electronic health records, becoming one of only ... July, according to a report from the Health IT Policy ... the National Coordinator for Health Information Technology (ONC-HIT). ...
Cached Medicine Technology:LABSCO Hires George Willett as New Vice President and Chief Financial Officer 2Faith Community Hospital Joins Meaningful Use Trailblazers 2Faith Community Hospital Joins Meaningful Use Trailblazers 3
(Date:6/30/2015)... ... June 30, 2015 , ... ... The company provides high quality record management services for patient records. Medical imaging ... normally required by physicians and clinics. , With the increase in the ...
(Date:6/30/2015)... ... 2015 , ... India Network Foundation today announced a new PPO ... insurance plans that provides coverage for visitors to the United States. The First ... obtain services from most experienced health care professional close to their location. , One ...
(Date:6/30/2015)... ... June 30, 2015 , ... The campaign aims to ... tract, the different forms of digestive disorders over 70 million Americans face and inspiring ... their system in tip-top shape. , The print component of “Digestive Wellness” is distributed ...
(Date:6/30/2015)... ... June 30, 2015 , ... People who want to learn ... of a near-death experience (NDE) – and also want to understand why the ... – are invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP their attendance ...
(Date:6/30/2015)... ... ... Bill Howe Plumbing, Inc. is one of the largest ... all employees ample opportunity for education and training in their field, paid for ... of San Diego (PHCC-SD). The San Diego plumbing company has been ...
Breaking Medicine News(10 mins):Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:Mediaplanet’s “Digestive Wellness” Campaign Urges You To Listen to What Your Stomach Is Telling You and Talk About It 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3
... of Michigan and the Mayo Clinic say that the flagship ... women who inherit a common genetic variation. // ,This ... of a crucial enzyme that is vital to activate tamoxifen ... Rae, Ph.D., at the University of Michigan Comprehensive Cancer Center ...
... health businesses are likely to be extensively affected when an ... to result in a 14% contraction in the goods and ... to the Pacific Pandemic Forum for Business. This is the ... amount of damage it will inflict on business and health ...
... suffered over 22,000 physical assaults and verbal abuses in 2004 ... nurses demanding more protection. //Nurses also face the chances of ... are not uncommon either. ,The country’s nursing ... emergency workers, to protect nurses also. The matter will also ...
... Singapore by Balaji Sadasivan, the Senior Minister of State for Health. ... children who are HIV positive to cope with the treatment they ... Fund, which has over US$ 200,000 already. ,As ... accounted for by women, who continue to remain a vulnerable group. ...
... took the world by storm by claiming to have cloned ... the journal Science, his colleague Roh Sung-il has alleged.// ,Roh ... paper analysis were taken from his stem cell lines since ... virus. “Without any cloned stem cells, he presented stem cells ...
... Committee as formed a new cabinet committee to plan strategies ... committee has said that though the United Kingdom //Government has ... bird flu spread but the committee feels still a lot ... ,The committee feels that the Government should organize the ...
Cached Medicine News:
... D-Type can combine a number of ... microplates on a simple to use ... is a multifunctional stand-alone device but ... robotic systems. Custom and standard add-on ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
Medicine Products: